top of page
News & Publications
Recent News
The Oklahoma News Report Discusses Bacterial Pneumonia and our MVX01 Vaccine
See the TV news report here, starting at 25:21, which discusses our MVX01 vaccine and includes comments from Matrivax’ CSO Kevin Killeen and our collaborator Prof Rodney Tweeten of the Oklahoma University Medical School.
October 27, 2023
Publications
Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid
Thanawastien A, Joyce KE, Cartee RT, Haines, LA, Pelton SI, Tweten RK, Killeen KP. Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid. Vaccine 2021; 39(11):1652-1660.
Online 2020: https://doi.org/10.1016/j.vaccine.2020.04.064 2020
bottom of page